Exicure

Biotech

Exicure exodus: CEO resigns, CTO exits, 3 board members depart

Exicure becomes a shell of its former self with exits of CEO, chief medical officer, chief technology officer and three board members amid staff cuts.
Kyle LaHucik Feb 4, 2022 9:58am

Ipsen commits up to $1B to Exicure for two rare neuro assets

Aug 2, 2021 10:41am

Northwestern U's novel RNA drug shows promise in brain cancer

Mar 10, 2021 2:00pm

Allergan pays Exicure $25M to discover hair loss drugs

Nov 14, 2019 7:00am

Exicure plans checkpoint combo after TLR9 drug clears early test

Sep 20, 2018 7:25am

Immune cell compound could treat multiple autoimmune diseases

Apr 20, 2018 2:01pm